Assessing HDL Anti-Inflammatory Capacity May Aid CV Risk Prediction
WEDNESDAY, April 28, 2021 -- Measuring high-density lipoprotein (HDL) anti-inflammatory capacity may improve cardiovascular disease risk assessment, according to a study published online April 12 in Circulation.
Congzhuo Jia, M.D., from University of Groningen in the Netherlands, and colleagues assessed whether HDL anti-inflammatory capacity was prospectively associated with first cardiovascular events in the general population. The analysis included 340 cases experiencing a first cardiovascular event and followed for a median of 10.5 years as well as matched controls with baseline samples.
The researchers found that HDL anti-inflammatory capacity was not associated with HDL cholesterol or high-sensitivity C-reactive protein. HDL anti-inflammatory capacity was significantly lower in cases compared with controls (31.6 versus 27.0 percent) and was inversely associated with incident cardiovascular disease in a fully adjusted model (odds ratio [OR] per one standard deviation [SD], 0.74). Similar associations were seen for all individual components of the cardiovascular disease end point. There was no association observed between HDL anti-inflammatory capacity and cholesterol efflux capacity. When efflux and anti-inflammatory capacity were combined in one adjusted model, both were significantly and independently associated with incident cardiovascular disease (efflux: OR per one SD, 0.74; anti-inflammatory capacity: OR per one SD, 0.66). Risk prediction using the Framingham risk score was improved by adding HDL anti-inflammatory capacity.
"The HDL anti-inflammatory capacity could represent a novel pharmacological intervention target for improving cardiovascular disease risk," the authors write.
One author reported ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
WEDNESDAY, May 12, 2021 -- About half of trainee cardiologists report being comfortable with use of telemedicine, and most express the need for telemedicine-specific training,...
MONDAY, May 10, 2021 -- Elevated systolic blood pressure, high serum total cholesterol, and obesity from childhood through adulthood are inversely associated with midlife...
FRIDAY, May 7, 2021 -- Bone mineral density (BMD) has independent prognostic value for predicting atherosclerotic cardiovascular disease (ASCVD) in women, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.